111 related articles for article (PubMed ID: 25665819)
1. The stochastic system approach for estimating dynamic treatments effect.
Commenges D; Gégout-Petit A
Lifetime Data Anal; 2015 Oct; 21(4):561-78. PubMed ID: 25665819
[TBL] [Abstract][Full Text] [Related]
2. Dynamic models for estimating the effect of HAART on CD4 in observational studies: Application to the Aquitaine Cohort and the Swiss HIV Cohort Study.
Prague M; Commenges D; Gran JM; Ledergerber B; Young J; Furrer H; Thiébaut R
Biometrics; 2017 Mar; 73(1):294-304. PubMed ID: 27461460
[TBL] [Abstract][Full Text] [Related]
3. Instrumental variables and inverse probability weighting for causal inference from longitudinal observational studies.
Hogan JW; Lancaster T
Stat Methods Med Res; 2004 Feb; 13(1):17-48. PubMed ID: 14746439
[TBL] [Abstract][Full Text] [Related]
4. Dealing with death when studying disease or physiological marker: the stochastic system approach to causality.
Commenges D
Lifetime Data Anal; 2019 Jul; 25(3):381-405. PubMed ID: 30448970
[TBL] [Abstract][Full Text] [Related]
5. Estimating the causal effect of zidovudine on CD4 count with a marginal structural model for repeated measures.
Hernán MA; Brumback BA; Robins JM
Stat Med; 2002 Jun; 21(12):1689-709. PubMed ID: 12111906
[TBL] [Abstract][Full Text] [Related]
6. Can we believe the DAGs? A comment on the relationship between causal DAGs and mechanisms.
Aalen OO; Røysland K; Gran JM; Kouyos R; Lange T
Stat Methods Med Res; 2016 Oct; 25(5):2294-2314. PubMed ID: 24463886
[TBL] [Abstract][Full Text] [Related]
7. Joint longitudinal data analysis in detecting determinants of CD4 cell count change and adherence to highly active antiretroviral therapy at Felege Hiwot Teaching and Specialized Hospital, North-west Ethiopia (Amhara Region).
Seyoum A; Ndlovu P; Temesgen Z
AIDS Res Ther; 2017 Mar; 14(1):14. PubMed ID: 28302125
[TBL] [Abstract][Full Text] [Related]
8. Bayesian inference for causal mediation effects using principal stratification with dichotomous mediators and outcomes.
Elliott MR; Raghunathan TE; Li Y
Biostatistics; 2010 Apr; 11(2):353-72. PubMed ID: 20101045
[TBL] [Abstract][Full Text] [Related]
9. The effects of highly active antiretroviral therapy (HAART) of stavudine, lamivudine and nevirapine on the CD4 lymphocyte count of HIV-infected Africans: the Nigerian experience.
Erhabor O; Ejele OA; Nwauche CA
Niger J Clin Pract; 2006 Dec; 9(2):128-33. PubMed ID: 17319344
[TBL] [Abstract][Full Text] [Related]
10. Marginal structural models for estimating the effect of highly active antiretroviral therapy initiation on CD4 cell count.
Cole SR; Hernán MA; Margolick JB; Cohen MH; Robins JM
Am J Epidemiol; 2005 Sep; 162(5):471-8. PubMed ID: 16076835
[TBL] [Abstract][Full Text] [Related]
11. An information criterion for marginal structural models.
Platt RW; Brookhart MA; Cole SR; Westreich D; Schisterman EF
Stat Med; 2013 Apr; 32(8):1383-93. PubMed ID: 22972662
[TBL] [Abstract][Full Text] [Related]
12. Stochastic differential equations as a tool to regularize the parameter estimation problem for continuous time dynamical systems given discrete time measurements.
Leander J; Lundh T; Jirstrand M
Math Biosci; 2014 May; 251():54-62. PubMed ID: 24631177
[TBL] [Abstract][Full Text] [Related]
13. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.
Kaufmann GR; Perrin L; Pantaleo G; Opravil M; Furrer H; Telenti A; Hirschel B; Ledergerber B; Vernazza P; Bernasconi E; Rickenbach M; Egger M; Battegay M;
Arch Intern Med; 2003 Oct; 163(18):2187-95. PubMed ID: 14557216
[TBL] [Abstract][Full Text] [Related]
14. Declines in highly active antiretroviral therapy initiation at CD4 cell counts ≤ 200 cells/μL and the contribution of diagnosis of HIV at CD4 cell counts ≤ 200 cells/μL in British Columbia, Canada.
Lourenço L; Samji H; Nohpal A; Chau W; Colley G; Lepik K; Barrios R; Lima V; Hogg RS; Montaner J; Kesselring S; Moore DM
HIV Med; 2015 Jul; 16(6):337-45. PubMed ID: 25721157
[TBL] [Abstract][Full Text] [Related]
15. History-adjusted marginal structural models for estimating time-varying effect modification.
Petersen ML; Deeks SG; Martin JN; van der Laan MJ
Am J Epidemiol; 2007 Nov; 166(9):985-93. PubMed ID: 17875580
[TBL] [Abstract][Full Text] [Related]
16. Assessing the causal effect of policies: an example using stochastic interventions.
Díaz I; van der Laan MJ
Int J Biostat; 2013 Nov; 9(2):161-74. PubMed ID: 24246287
[TBL] [Abstract][Full Text] [Related]
17. Treatment interruption of highly active antiretroviral therapy in patients with nadir CD4 cell counts >200 cells/mm3.
Toulson AR; Harrigan R; Heath K; Yip B; Brumme ZL; Harris M; Hogg RS; Montaner JS
J Infect Dis; 2005 Nov; 192(10):1787-93. PubMed ID: 16235178
[TBL] [Abstract][Full Text] [Related]
18. Population intervention causal effects based on stochastic interventions.
Muñoz ID; van der Laan M
Biometrics; 2012 Jun; 68(2):541-9. PubMed ID: 21977966
[TBL] [Abstract][Full Text] [Related]
19. Patterns, predictors, and consequences of initial regimen type among HIV-infected women receiving highly active antiretroviral therapy.
Golub ET; Benning L; Sharma A; Gandhi M; Cohen MH; Young M; Gange SJ
Clin Infect Dis; 2008 Jan; 46(2):305-12. PubMed ID: 18171267
[TBL] [Abstract][Full Text] [Related]
20. Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country.
Kilaru KR; Kumar A; Sippy N; Carter AO; Roach TC
HIV Med; 2006 Mar; 7(2):99-104. PubMed ID: 16420254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
